nVerses Capital’s Chemed CHE Stock Holding History

nVerses Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-700	Closed	-$421K	–	165
2024 Q3	$421K	Buy	700 +100	+17%	+$56.7K	0.19%	163
2024 Q2	$326K	Buy	+600	New	+$344K	0.19%	172

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

nVerses Capital's CHE Position: Q4 2024 in Review

nVerses Capital sold out of Chemed (CHE) in Q4 2024, closing a stake of 700 shares — an estimated $421K sold.

nVerses Capital first reported a position in CHE in Q2 2024 and held it in 2 quarters. The position peaked at $421K in Q3 2024. 528 funds tracked by Wall St. Rank hold CHE as of Q4 2024.

nVerses Capital reported no remaining Chemed position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 700 Chemed shares in Q4 2024, an estimated $421K.
nVerses Capital first reported a position in Chemed in Q2 2024 and held it in 2 quarters.
nVerses Capital's Chemed position peaked at $421K in Q3 2024.
528 funds tracked by Wall St. Rank held Chemed as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.